Cefovecin Sodium 800 mg
Dogs- Treatment of skin infections (secondary superficial pyoderma, abscesses, and wounds) in dogs caused by susceptible strains of Staphylococcus intermedius and Streptococcus canis (Group G)
Cats- Treatment of skin infections (wounds and abscesses) in cats caused by susceptible strains of Pasteurella multocida.
Dosing & Administration:
Aseptically reconstitute CONVENIA® with 10 mL sterile water for injection. Shake and allow vial to sit until all material is visually dissolved. The resulting solution contains cefovecin sodium equivalent to 80 mg/mL cefovecin.
8mg/kg (0.1 mL/kg) body weight subcutaneously in dogs and cats above 4 months of age.
A second subcutaneous injection of CONVENIA® may be administered in dogs if response to therapy is not complete.
The decision for a second injection for any individual dog should take into consideration such factors as progress toward clinical resolution, the susceptibility of the causative organisms, and the integrity of the dog’s host-defense mechanisms.
Important safety information:
CONVENIA® is contraindicated in dogs and cats with known allergy to cefovecin or to β-lactam (penicillins and cephalosporins) group antimicrobials. The safe use of CONVENIA® in dogs or cats less than 4 months of age (see Animal Safety) and in breeding or lactating animals has not been determined. Safety has not been established for IM or IV administration. The long-term effects on injection sites have not been determined.
10 ml multiuse vial containing 800 mg of Cefovecin sodium as lyophilized cake.